Transdermal Drug Delivery Systems Market Size & Share 2023 to 2032
Market Size by Type (Transdermal Patches, Transdermal Semisolids) by Application (Pain Management, Hormonal Applications, Central Nervous System Disorders.
Download Free PDF
Market Size by Type (Transdermal Patches, Transdermal Semisolids) by Application (Pain Management, Hormonal Applications, Central Nervous System Disorders.
Download Free PDF
Starting at: $2,450
Base Year: 2022
Companies Profiled: 10
Tables & Figures: 334
Countries Covered: 27
Pages: 195
Download Free PDF
Transdermal Drug Delivery Systems Market
Get a free sample of this report
Transdermal Drug Delivery System Market Size
Transdermal Drug Delivery System Market size amassed over USD 29 billion in revenue in 2022. The industry is anticipated to witness over 8% CAGR between 2023 and 2032, owing to a remarkable surge in incidences of chronic ailments.
Transdermal Drug Delivery Systems Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
expenditure on health and boosted investments in R&D projects focused on enhancing medicine and route of administration. For instance, the Centers for Disease Control and Prevention data suggests that chronic diseases are one of the prime drivers of annual healthcare costs of $4.1 trillion in the U.S. These factors, in line with the continuous technological developments in the drug delivery system, will augment market share.
In contrast, the limited number of approved medications and transdermal drug delivery systems worldwide may hamper industry performance. Also, the transdermal treatment route is not considered suitable as it may cause drug irritation or skin sensitivity, hindering the market landscape. Alongside the development, recall, and failure of a transdermal drug delivery system (TDDS) associate high costs, which may further act as a growth restraint over the forecast timeframe.
Transdermal Drug Delivery System Market Analysis
With respect to type, the transdermal patches segment of the transdermal drug delivery system market is expected to garner over USD 35.5 billion by 2032. Patches are classified into matrix patches, drug-in-adhesive patches, microneedle patches, and reservoir membrane patches. The increasing prevalence of several chronic conditions, such as cardiovascular diseases, cancer, and others, will supplement the market progress.
Transdermal drug delivery system market from the pain management segment is poised to record a valuation of over USD 19.5 billion by 2032. Opioid patches are extensively used in pain management applications, spurring market growth. Furthermore, the increasing prevalence of cancer, resulting in the accelerated embracing of pain patches.
Transdermal drug delivery system market from hospitals segment is likely to emerge as a major consumer of transdermal drug delivery systems, accounting for over USD 17 billion by 2032. A large patient population undergoing treatment for a variety of disorders will accelerate product adoption across hospital settings. Furthermore, the availability of a wide range of medical services in these establishments will transform business dynamics.
North America transdermal drug delivery system market accumulated over 46.% of revenue share in 2022 and is speculated to attain a healthy CAGR through 2032. Growing adoption of unhealthy lifestyles among individuals, such as alcohol consumption, smoking, and lack of exercise, will boost the disease rate, thereby fostering the market trends.
Transdermal Drug Delivery System Market Share
Key players in the transdermal drug delivery system market are:
Companies operating in this business vertical are indulging strategic associations and drug R&D projects to strengthen their market standing.
Impact of the COVID-19 pandemic
The COVID-19 pandemic had a damaging impact on the transdermal drug delivery system industry. The stringent lockdown measures implemented by numerous governments worldwide created a huge gap in product demand and supply, thus, resulting in a decline in the sales of transdermal drug delivery systems. Furthermore, reduced patient visits to the hospital due to delays and cancellation of elective medical procedures further limited product uptake, thus, impacting the trade dynamics during the crisis.
The transdermal drug delivery system market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Type
By Application
By End-use
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →